Recent CLSD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:15:04 PM
- Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors • GlobeNewswire Inc. • 11/04/2024 12:05:00 PM
- Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024 • GlobeNewswire Inc. • 10/31/2024 11:05:00 AM
- Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting • GlobeNewswire Inc. • 10/22/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 11:55:13 AM
- Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes • GlobeNewswire Inc. • 10/09/2024 10:30:00 AM
- Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 08/27/2024 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:15:08 PM
- Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/08/2024 11:05:00 AM
- Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 11:55:18 AM
- Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET • GlobeNewswire Inc. • 07/22/2024 04:00:00 PM
- Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board • GlobeNewswire Inc. • 07/11/2024 11:05:00 AM
- Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery • GlobeNewswire Inc. • 06/27/2024 11:05:00 AM
- Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/12/2024 11:05:00 AM
- Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® • GlobeNewswire Inc. • 05/21/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 08:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:43 PM
- Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/08/2024 08:15:00 PM
- Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/30/2024 11:05:00 AM
- Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors • GlobeNewswire Inc. • 04/16/2024 11:05:00 AM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM